XClose

UCL Institute of Neurology

Home
Menu

UCL Institute of Neurology

Research and teaching excellence

The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases.  A number of important research centres are based at the Institute, including the MRC Prion Unit, MRC Centre for Neuromuscular Diseases and the Wellcome Trust Centre for Neuroimaging

Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience. 

The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.

What We Do

Please see our Infographic highlighting key data on the Institute.

Discovery research

The overarching research mission of the Institute is to undertake world class discovery neuroscience and translate it into improved diagnostics and treatments for patients.

Translational science

The Institute aims to be the translational experimental medicine hub of UCL Neuroscience, translating pre-clinical science into experimental medicine research

Study

Queen Square is an international leader in the provision of research-led education in clinical neuroscience and has a leadership role in clinical training nationally.

IoN News

Dr Stephen Fleming wins the Wiley Prize in Psychology

The British Academy has announced the 2016 winners of its prizes and medals, and we are delighted that Dr Stephen Fleming (Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology) has won the Wiley Prize for Psychology, for his contribution to the study of the neuropsychology of human metacognition.

Published: Sep 27, 2016 9:55:50 AM

Trial shows signs new Alzheimer's drug could benefit early-stage patients

Dr Cath Mummery, head of clinical trials at the Dementia Research Centre, UCL Institute of Neurology, was interviewed on BBC News and Channel 4 yesterday evening about the interim results of a Phase I study of adecanumab, a monoclonal antibody, reported in Nature.

Published: Sep 1, 2016 6:00:00 PM

Science begins in the new Francis Crick Institute building

The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.

Published: Sep 1, 2016 5:57:11 PM